TeleHealth Med Review
Best for: Buyers seeking a Georgia-based, Inc.-incorporated telehealth platform with LegitScript verification, explicit 503A pharmacy designation, verbatim FDA compounded disclaimer, and honest testimonial-compensation disclosure — strong fit for transparency-conscious cash-pay patients who want HSA/FSA acceptance and both injectable and sublingual GLP-1 form options.
TeleHealth Med (telehealthmed.com) is an Evans, Georgia-based telehealth weight-loss platform offering compounded GLP-1 (semaglutide and tirzepatide) in both injectable and sublingual forms. Corporate entity EXPLICITLY disclosed: 'TeleHealth Med, Inc.' (Inc. designation in footer copyright '© 2026 TeleHealth Med, Inc. All rights reserved'). Pricing: 'As low as $147.00/month.' LegitScript Certified — verification link displayed (legitscript.com/websites/?checker_keywords=telehealthmed.com), specific ID not visible in text form. Verbatim FDA compounded-medication disclaimer published: 'The FDA has not approved or evaluated compounded medications regarding their safety, quality, or effectiveness.' Pharmacy partner (FAQ verbatim): 'Our 503A pharmacies are regulated by the FDA and also licensed by their respective state boards.' US-licensed + board-certified clinicians operating exclusively within the United States. Phone 1-833-865-8118. Email support@telehealthmed.com. HSA and FSA accepted. No insurance required. Notable: site explicitly discloses 'Testimonials are compensated. Customer images are user-submitted, and individual results have not undergone independent verification' — uncommon honest disclosure. Site disclaims: 'This website is not a pharmacy or healthcare provider. Medical services and prescription fulfillment...' Claims '100,000+ treatments successfully filled' and '98% high patient achievement rate.' Subscription cancellation allowed; refunds may be proportionally adjusted for promotional discounts; non-refundable for partially utilized subscription periods. Multiple medical-board license-verification footer links (California, Massachusetts, Rhode Island, Vermont) appear to reference state-licensure verification resources, not necessarily exhaustive states-served list. Affiliate tracking via panoramatrack.com (NOT the standard Katalys/RevOffers pattern). Captured via Chrome MCP since site 403s on WebFetch. Live-verified 2026-05-19.
Medium confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
TeleHealth Med is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
TeleHealth Med prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Starting tier — TeleHealth Med GLP-1 | compounded | $147 |
✓ Pros
- •Corporate Inc. entity explicitly disclosed (TeleHealth Med, Inc.) — clearer accountability than LLC-or-undisclosed competitors
- •Verbatim FDA compounded-medication disclaimer published — meets WLR transparency standard
- •503A pharmacy designation explicitly stated in FAQ (verbatim)
- •**Honest testimonial-compensation disclosure** — verbatim 'Testimonials are compensated. Customer images are user-submitted, and individual results have not undergone independent verification.' Uncommon honest framing vs DTC competitors that present testimonials as organic
- •Both injectable AND sublingual forms offered (per FAQ — auto-classifies into /best/oral-glp1-providers via description regex)
- •HSA / FSA accepted — uncommon in DTC compounded-GLP-1 market
- •Phone support published (1-833-865-8118) with business-hours coverage
- •LegitScript verification link active
- •$147/mo entry pricing is competitive with the DTC market
✗ Cons
- •Specific 503A pharmacy partner NOT named (only generic '503A pharmacies' framing)
- •LegitScript ID NUMBER not visible in text form (only the verification link)
- •Full states-served list NOT explicitly disclosed — footer references CA/MA/RI/VT for license-verification resources but these are not framed as the exhaustive states-served list
- •Named medical director / clinical leadership NOT disclosed
- •Affiliate tracking uses panoramatrack.com (NOT the standard Katalys/RevOffers pattern other WLR providers use)
- •Pricing dose tiers beyond starting $147/mo NOT disclosed publicly
- •Refund policy partially restrictive — 'no refunds for partially utilized subscription periods or bundled packages'; 'Refunds for canceled services may be proportionally adjusted if initial promotional discounts'
- •Compounded-tirzepatide pricing NOT explicitly stated on homepage (only main heading lists 'GLP-1, Semaglutide & Tirzepatide')
- •Site disclaims being a pharmacy or healthcare provider — common DTC framing but worth noting for accountability-conscious buyers
- •'100,000+ treatments' + '98% achievement rate' claims not independently verified
Ready to start with TeleHealth Med?
Starting at $147/month. See current pricing and start your free consultation.
Sources & methodology
Our TeleHealth Med review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to TeleHealth Med
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with TeleHealth Med?
Starting at $147/month. See current pricing and start your free consultation.